Paper24673373
Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.
Fang RH and 7 others. Nano Lett, 2014. Cited by 1,120 papers, by iCite.
Cite this record
ConductScience Library. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Papers, record 24673373. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24673373
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Cancer Vaccines | Major topic |
| Cell Membrane | Major topic |
| Drug Delivery Systems | Major topic |
| Nanoparticles | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Humans | |
| Immunotherapy | |
| Mice, Inbred C57BL | |
| Nanomedicine |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R25CA153915 | NCI NIH HHS | United States | R25CA153915 | PubMed | NIH RePORTER |
| R01 DK095168 | NIDDK NIH HHS | United States | R01DK095168 | PubMed and NIH | NIH RePORTER |
| R01DK095168 | NIDDK NIH HHS | United States | R01DK095168 | PubMed and NIH | NIH RePORTER |
| P30 CA023100 | NCI NIH HHS | United States | P30CA023100 | PubMed and NIH | NIH RePORTER |
| R25 CA153915 | NCI NIH HHS | United States | R25CA153915 | PubMed | NIH RePORTER |
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18654426 | Nanocarriers as an emerging platform for cancer therapy. | Nat Nanotechnol | 2007 | https://conductscience.org/library/papers/18654426 | PubMed |
| 2 | 17981204 | Regulation of interferon-gamma during innate and adaptive immune responses. | Adv Immunol | 2007 | https://conductscience.org/library/papers/17981204 | PubMed |
| 3 | 12839977 | Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. | Cancer Res | 2003 | https://conductscience.org/library/papers/12839977 | PubMed |
| 4 | 17873867 | Exploiting lymphatic transport and complement activation in nanoparticle vaccines. | Nat Biotechnol | 2007 | https://conductscience.org/library/papers/17873867 | PubMed |
| 5 | 17569868 | The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. | Science | 2007 | https://conductscience.org/library/papers/17569868 | PubMed |
| 6 | 22332936 | Nanoparticles disguised as red blood cells to evade the immune system. | Expert Opin Biol Ther | 2012 | https://conductscience.org/library/papers/22332936 | PubMed |
| 7 | 16651452 | Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors. | Cancer Res | 2006 | https://conductscience.org/library/papers/16651452 | PubMed |
| 8 | 23786263 | Reconstructed stem cell nanoghosts: a natural tumor targeting platform. | Nano Lett | 2013 | https://conductscience.org/library/papers/23786263 | PubMed |
| 9 | 17558426 | The perfect mix: recent progress in adjuvant research. | Nat Rev Microbiol | 2007 | https://conductscience.org/library/papers/17558426 | PubMed |
| 10 | 24280870 | Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies. | Nanoscale | 2014 | https://conductscience.org/library/papers/24280870 | PubMed |
| 11 | 18697944 | The effect of particle design on cellular internalization pathways. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18697944 | PubMed |
| 12 | 23184788 | Erythrocyte-inspired delivery systems. | Adv Healthc Mater | 2012 | https://conductscience.org/library/papers/23184788 | PubMed |
| 13 | 10856220 | Role of CD47 as a marker of self on red blood cells. | Science | 2000 | https://conductscience.org/library/papers/10856220 | PubMed |
| 14 | 8400144 | Adhesion molecules in tumor metastasis. | Semin Cancer Biol | 1993 | https://conductscience.org/library/papers/8400144 | PubMed |
| 15 | 12438311 | MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12438311 | PubMed |
| 16 | 22899335 | Preparation of multifunctional nanoparticles and their assemblies. | Nat Protoc | 2012 | https://conductscience.org/library/papers/22899335 | PubMed |
| 17 | 22641380 | Engineering nano- and microparticles to tune immunity. | Adv Mater | 2012 | https://conductscience.org/library/papers/22641380 | PubMed |
| 18 | 21631324 | gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21631324 | PubMed |
| 19 | 19721436 | Rethinking therapeutic cancer vaccines. | Nat Rev Drug Discov | 2009 | https://conductscience.org/library/papers/19721436 | PubMed |
| 20 | 8349740 | Homophilic adhesion between Ig superfamily carcinoembryonic antigen molecules involves double reciprocal bonds. | J Cell Biol | 1993 | https://conductscience.org/library/papers/8349740 | PubMed |
Cited by589
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,120 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943937 | Construction and Functional Engineering of Bio-Integrated Micro/Nanorobots for Theranostic Applications. | Micromachines (Basel) | 2026 | https://conductscience.org/library/papers/42943937 | PubMed |
| 42942844 | Cell Membrane-Coated Nanoparticles as Biomimetic Drug Delivery Systems: Design, Therapeutic Applications, and Translational Challenges. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942844 | PubMed |
| 42892943 | EGFR-antibody-decorated cancer-cell-membrane-coated MOF nanoplatform enables targeted delivery of the STING agonist diABZI for pancreatic cancer immunotherapy. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42892943 | PubMed |
| 42856429 | Single-Particle STORM Imaging Quantifies Coating Heterogeneity Among Cell Membrane-Coated Nanoparticles. | bioRxiv | 2026 | https://conductscience.org/library/papers/42856429 | PubMed |
| 42851668 | A Trojan horse nanoplatform overcoming delivery barriers for targeted gene immunotherapy of colorectal cancer. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42851668 | PubMed |
| 42822783 | In Vitro Investigation of LIFU-Triggered, Visualizable Bionic Nanoparticles for a "Three-In-One" Therapy Against Medullary Thyroid Carcinoma. | Technol Cancer Res Treat | 2026 | https://conductscience.org/library/papers/42822783 | PubMed |
| 42816842 | Tumor cell membrane‑coated MOF‑199 nanoparticles co‑loaded with auranofin and celecoxib enhance single‑dose radiotherapy and anti‑PD‑L1 therapy in cervical cancer. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42816842 | PubMed |
| 42811335 | Targeting cancer-associated fibroblasts: therapeutic strategies, translational challenges, and future perspectives. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42811335 | PubMed |
| 42797238 | Layer by Layer Engineered Lipid-Based Nanocarriers for Therapeutic Delivery and Next-Generation Design. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42797238 | PubMed |
| 42781594 | Bioinspired and Biomimetic Nanocarriers: Advances in Exosomes and Cell-Membrane-Coated Systems for Therapeutic Applications. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42781594 | PubMed |
| 42771161 | Smart drug delivery systems for immunotherapeutic agents: focus on biological/biogenic platform-based intelligent delivery in cancer immunotherapy. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/42771161 | PubMed |
| 42730348 | Micro/Nanorobots (MNRs) at the Intersection of Mechanobiology and Artificial Intelligence: An Emerging Frontier for Precision Nanomedicine. | ACS Nano Med | 2026 | https://conductscience.org/library/papers/42730348 | PubMed |
| 42719493 | Photodynamically Sensitized Mitochondrial-Damage Amplification Strategy Promotes Pyroptosis-Induced Immunotherapy of Osteosarcoma. | Biomater Res | 2026 | https://conductscience.org/library/papers/42719493 | PubMed |
| 42719113 | Advances in nanomaterial-based delivery systems for inducing transplantation tolerance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42719113 | PubMed |
| 42715057 | Biomimetic Virus-Like Mesoporous Silica Nanoparticles Activate NK Cells Indirectly via Monocyte Crosstalk. | Nano Lett | 2026 | https://conductscience.org/library/papers/42715057 | PubMed |
| 42709284 | Nanomedicine beyond carriers - devices, cells & living therapeutics. | Biomed Microdevices | 2026 | https://conductscience.org/library/papers/42709284 | PubMed |
| 42670442 | Theragenerative Nanomaterials: Integrating Therapy, Regeneration, and Diagnosis-Navigating the Shared Pathways Between Tissue Repair and Malignancy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42670442 | PubMed |
| 42639936 | From Cell-Derived Vesicles to Hybrid Nanovectors: Biological Membranes as Functional Blueprints for Gene Delivery. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42639936 | PubMed |
| 42605503 | Precisely Engineering Biomimetic Nanoparticles via Controlled Cell Membrane Coating. | Small | 2026 | https://conductscience.org/library/papers/42605503 | PubMed |
| 42590834 | Targeted delivery of mRNA to immune cells for in vivo cell therapy. | Drug Deliv | 2026 | https://conductscience.org/library/papers/42590834 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24673373
GET https://conductscience.org/api/papers/v1/24673373/references?page=2